US · Healthcare

Aida Pharmaceuticals Inc (AIDA)

Drug Manufacturers - Specialty & Generic

Aida Pharmaceuticals Inc (AIDA) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for AIDA

P/E ratio

18.00

Aida Pharmaceuticals Inc (AIDA) — FAQ

What is AIDA's P/E ratio?

The price-to-earnings (P/E) ratio for Aida Pharmaceuticals Inc (AIDA) is 18.00 (data as of 2026-03-23).

Does Aida Pharmaceuticals Inc pay a dividend?

Dividend yield is not available in the current snapshot for Aida Pharmaceuticals Inc (AIDA). Check the MyAverix Finance app for the latest dividend data.

What sector is Aida Pharmaceuticals Inc in?

Aida Pharmaceuticals Inc (AIDA) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is AIDA listed on?

AIDA is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)